<https://www.asktraders.com/analysis/salarius-pharmaceuticals-shares-climb-after-initiating-expansion-of-seclidemstat-trial/#webpage>
<http://schema.org/description>
"Salarius Pharmaceuticals (NASDAQ: SLRX) announced on Wednesday the initiation of the expansion of its ongoing 1-2 clinical trial of seclidemstat in patients with relapsed and refractory Ewing sarcoma and Ewing related sarcomas."
<https://www.asktraders.com/analysis/salarius-pharmaceuticals-shares-climb-after-initiating-expansion-of-seclidemstat-trial/>